Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Country / region: Spain Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20131
20161
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardurion Pharmaceuticals, Inc.2
Instituto de Investigación Hospital Universitario La Paz1
KAI Pharmaceuticals1
National Research Council, Spain1
Novartis Pharmaceuticals1
Pierre Fabre Medicament1
Pulmovant, Inc.1
Sanifit Therapeutics S. A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases9
Heart Diseases3
Heart Failure2
Atherosclerosis1
Atrial Fibrillation1
Calcinosis1
Cardiovascular Abnormalities1
Fibrosis1
HIV Infections1
Heart Failure, Diastolic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.